Update der S3-Leitlinie für maligne Ovarialtumoren 2016. Rolle der Pathologie in Diagnostik, Therapie und Nachsorge epithelialer Tumoren

Staebler, A. und Mayr, D. (2017): Update der S3-Leitlinie für maligne Ovarialtumoren 2016. Rolle der Pathologie in Diagnostik, Therapie und Nachsorge epithelialer Tumoren. In: Pathologe, Bd. 38, Nr. 4: S. 331-342

Abstract

Tumor stage, residual postoperative tumor, histological type and grading are considered among the main prognostic parameters in the consensus-based recommendations in the new S3 guidelines for diagnosis, treatment and clinical follow-up of malignant tumours of the ovary. Based on the 2014 update of the WHO Classification of Tumours of the Female Reproductive Organs this article summarizes the most significant changes. For example now the same TNM and FIGO classification applies for tumours of the ovary, peritoneum or fallopian tube. Noninvasive implants of serous borderline tumours are now named implants. In contrast, invasive implants are regarded as low-grade serous carcinoma. By presenting the current background information, we want to provide a basis for discussion, regarding more detailed consensus recommendations for pathologists and clinicians in the future.

• Dokumententyp: Zeitschriftenartikel
• Fakultät: Medizin
• Themengebiete: 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit
• ISSN: 0172-8113
• Sprache: Deutsch